Risk factors for active tuberculosis in adults on highly active antiretroviral therapy in Africa

Comment

Catherine Seyler et al. AIDS. 2006.

. 2006 Jun 26;20(10):1463; author reply 1463-5.

doi: 10.1097/01.aids.0000233585.87338.79.

No abstract available

Comment on

Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.
Lawn SD, Badri M, Wood R. Lawn SD, et al. AIDS. 2005 Dec 2;19(18):2109-16. doi: 10.1097/01.aids.0000194808.20035.c1. AIDS. 2005. PMID: 16284460

Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy.
Santoro-Lopes G, de Pinho AM, Harrison LH, Schechter M. Santoro-Lopes G, et al. Clin Infect Dis. 2002 Feb 15;34(4):543-6. doi: 10.1086/338641. Epub 2002 Jan 7. Clin Infect Dis. 2002. PMID: 11797184
Impact of antiretroviral therapy on tuberculosis risk in different TB-HIV epidemics.
Middelkoop K. Middelkoop K. Int J Tuberc Lung Dis. 2010 Mar;14(3):261. Int J Tuberc Lung Dis. 2010. PMID: 20132613 No abstract available.
The sound of one hand clapping: tuberculosis and antiretroviral therapy in Africa.
De Cock KM, Marston B. De Cock KM, et al. Am J Respir Crit Care Med. 2005 Jul 1;172(1):3-4. doi: 10.1164/rccm.2504003. Am J Respir Crit Care Med. 2005. PMID: 15980107 Review. No abstract available.
Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
Nesheim SR, Kapogiannis BG, Soe MM, Sullivan KM, Abrams E, Farley J, Palumbo P, Koenig LJ, Bulterys M. Nesheim SR, et al. Pediatrics. 2007 Jul;120(1):100-9. doi: 10.1542/peds.2006-2052. Pediatrics. 2007. PMID: 17606567
Issues in the management of HIV-related tuberculosis.
Burman WJ. Burman WJ. Clin Chest Med. 2005 Jun;26(2):283-94, vi-vii. doi: 10.1016/j.ccm.2005.02.002. Clin Chest Med. 2005. PMID: 15837111 Review.